John Sellers

Cooley advised Baseten, the top inference platform for artificial intelligence (AI)-native products, on its $75 million Series C financing, bringing its total funding to $135 million.

Cooley advised Harvey, a domain-specific artificial intelligence (AI) platform for legal and professional services, on its $300 million Series D financing at a $3 billion valuation.

Cooley advised SiteOne Therapeutics, a biopharmaceutical company developing selective ion channel modulators for the treatment of pain, cough and other conditions, on its $100 million Series C financing.

Cooley advised Cresta, an end-to-end generative artificial intelligence (AI) platform for contact centers, on the closing of its $125 million Series D.

Cooley advised Archon Biosciences, a biotechnology company pioneering computationally designed antibody cages (AbCs) to unlock powerful therapeutic targets beyond the reach of existing modalities, on its $20 million seed financing led by Madrona Ventures.